This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Amerisourcebergen Corporation. The $1,404.96 firm fixed-price delivery order is for the supply of MENQUADFI VIAL 0.5ML medical products. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $53,183.02 firm fixed-price delivery order covers the supply of MENQUADFI VIAL 0.5ML medical products, with a completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,451.56, is a delivery order for "MENQUADFI VIAL 0.5ML" medical supplies. The contract has an ultimate completion date of April 8, 2025 and is a firm fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,281.73 firm fixed-price delivery order contract is for the supply of MENQUADFI VIAL 0.5ML medical products, with a completion date of July 15, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,104.81, is a Delivery Order for the supply of MENQUADFI VIAL 0.5ML medical products. The contract has an ultimate completion date of December 10, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $4,214.88 Firm Fixed Price Delivery Order is for the supply of "MENQUADFI VIAL 0.5ML" medical products. The contract has an ultimate completion date of May 10, 2024. Amerisourcebergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.56 Firm Fixed Price Delivery Order contract covers the supply of MENQUADFI VIAL 0.5ML medical products, with a period of performance through December 9, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor in the United States. The $3,507.65 firm fixed-price delivery order is for the supply of MENQUADFI VIAL 0.5ML, a medical product. The contract has a period of performance through September 27, 2024 and does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,947.55 firm fixed price delivery order is for MENQUADFI VIAL 0.5ML medical supplies, with a period of performance through January 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,911.68 firm fixed-price delivery order covers the supply of 4567773275 MENQUADFI VIAL 0.5ML, a medical product, with a period of performance through April 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...